🇪🇸 Spain · EU Public Tender
2019400022 — Prórroga de adquisición del fármaco omalizumab (Xolair)
🏛️ Servicio Madrileño de la Salud, Hospital Universitario Ramón y Cajal · 📍 Madrid
680 K€
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Awarded to | Novartis Farmaceútica, S. A. |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.